Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: a propensity score-matched cohort

Abstract

Background Familial adenomatous polyposis (FAP) is a rare inherited syndrome that predisposes the patient to cancer. Treatment of FAP-related ampullary lesions is challenging and the role of endoscopic papillectomy has not been elucidated. We retrospectively analyzed the outcomes of endoscopic papillectomy in matched cohorts of FAP-related and sporadic ampullary lesions (SALs).

Methods This retrospective multicenter study included 1422 endoscopic papillectomy procedures. Propensity score matching including age, sex, comorbidity, histologic subtype, and size was performed. Main outcomes were complete resection (R0), technical success, complications, and recurrence.

Results Propensity score matching identified 202 patients (101 FAP, 101 SAL) with comparable baseline characteristics. FAP patients were mainly asymptomatic (79.2 % [95 %CI 71.2–87.3] vs. 46.5 % [95 %CI 36.6–56.4]); P < 0.001). The initial R0 rate was significantly lower in FAP patients (63.4 % [95 %CI 53.8–72.9] vs. 83.2 % [95 %CI 75.8–90.6]; P = 0.001). After repeated interventions (mean 1.30 per patient), R0 was comparable (FAP 93.1 % [95 %CI 88.0–98.1] vs. SAL 97.0 % [95 %CI 93.7–100]; P = 0.19). Adverse events occurred in 28.7 %. Pancreatitis and bleeding were the most common adverse events in both groups. Severe adverse events were rare (3.5 %). Overall, 21 FAP patients (20.8 % [95 %CI 12.7–28.8]) and 16 SAL patients (15.8 % [95 %CI 8.6–23.1]; P = 0.36) had recurrence. Recurrences occurred later in FAP patients (25 [95 %CI 18.3–31.7] vs. 2 [95 %CI CI 0.06–3.9] months).

Conclusions Endoscopic papillectomy was safe and effective in FAP-related ampullary lesions. Criteria for endoscopic resection of ampullary lesions can be extended to FAP patients. FAP patients have a lifetime risk of relapse even after complete resection, and require long-time surveillance.

Publikationsverlauf

Eingereicht: 19. Mai 2022

Angenommen nach Revision: 06. Februar 2023

Accepted Manuscript online:
06. Februar 2023

Artikel online veröffentlicht:
19. April 2023

• References

• 1 Jemal A, Siegel R, Ward E. et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96
• 2 Ramai D, Ofosu A, Singh J. et al. Demographics, tumor characteristics, treatment, and clinical outcomes of patients with ampullary cancer: a Surveillance, Epidemiology, and End Results (SEER) cohort study. Minerva Gastroenterol Dietol 2019; 65: 85-90
• 3 Grobmyer SR, Stasik CN, Draganov P. et al. Contemporary results with ampullectomy for 29 “benign” neoplasms of the ampulla. J Am Coll Surg 2008; 206: 466-471
• 4 Powell SM, Petersen GM, Krush AJ. et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982-1987
• 5 Fischer HP, Zhou H. Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004; 11: 301-309
• 6 Kashiwagi H, Spigelman AD, Debinski HS. et al. Surveillance of ampullary adenomas in familial adenomatous polyposis. Lancet 1994; 344: 1582
• 7 Espinel J, Pinedo E, Ojeda V. et al. Endoscopic management of adenomatous ampullary lesions. World J Methodol 2015; 5: 127-135
• 8 Kahn MB, Rush Jr. BF. The overlooked technique of ampullary excision. Surg Gynecol Obstet 1989; 169: 253-254
• 9 Talamini MA, Moesinger RC, Pitt HA. et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997; 225: 590-599 discussion 599-600
• 10 Lee H, Park JY, Kwon W. et al. Transduodenal ampullectomy for the treatment of early-stage ampulla of Vater cancer. World J Surg 2016; 40: 967-973
• 11 van Heumen BW, Nieuwenhuis MH, van Goor H. et al. Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: a nationwide retrospective cohort study. Surgery 2012; 151: 681-690
• 12 Lepistö A, Kiviluoto T, Halttunen J. et al. Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis. Endoscopy 2009; 41: 504-509
• 13 Hong S, Song KB, Lee YJ. et al. Transduodenal ampullectomy for ampullary tumors – single center experience of consecutive 26 patients. Ann Surg Treat Res 2018; 95: 22-28
• 14 De Palma GD. Endoscopic papillectomy: indications, techniques, and results. World J Gastroenterol 2014; 20: 1537-1543
• 15 Heise C, Abou AliE, Hasenclever D. et al. Systematic review with meta-analysis: endoscopic and surgical resection for ampullary lesions. J Clin Med 2020; 9: 3622
• 16 Vanbiervliet G, Strijker M, Arvanitakis M. et al. Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021; 53: 429-448
• 17 Itoi T, Ryozawa S, Katanuma A. et al. Clinical practice guidelines for endoscopic papillectomy. Dig Endosc 2022; 34: 394-411
• 18 Gluck N, Strul H, Rozner G. et al. Endoscopy and EUS are key for effective surveillance and management of duodenal adenomas in familial adenomatous polyposis. Gastrointest Endosc 2015; 81: 960-966
• 19 Ouaïssi M, Panis Y, Sielezneff I. et al. Long-term outcome after ampullectomy for ampullary lesions associated with familial adenomatous polyposis. Dis Colon Rectum 2005; 48: 2192-2196
• 20 Ma T, Jang EJ, Zukerberg LR. et al. Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome. Surg Endosc 2014; 28: 2349-2356
• 21 Roos VH, Bastiaansen BA, Kallenberg FGJ. et al. Endoscopic management of duodenal adenomas in patients with familial adenomatous polyposis. Gastrointest Endosc 2021; 93: 457-466
• 22 Cecinato P, Parmeggiani F, Braglia L. et al. Endoscopic papillectomy for ampullary adenomas: different outcomes in sporadic tumors and those associated with familial adenomatous polyposis. J Gastrointest Surg 2021; 25: 457-466
• 23 Catalano MF, Linder JD, Chak A. et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 2004; 59: 225-232
• 24 Hollenbach M, Ali EA, Auriemma F. et al. Study protocol of the ESAP study: endoscopic papillectomy vs. surgical ampullectomy vs. pancreaticoduodenectomy for ampullary neoplasm – a Pancreas2000/EPC Study. Front Med 2020; 7: 152
• 25 Vandenbroucke JP, von Elm E, Altman DG. et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4: e297
• 26 Tsuji S, Itoi T, Sofuni A. et al. Tips and tricks in endoscopic papillectomy of ampullary tumors: single-center experience with large case series (with videos). J Hepatobiliary Pancreat Sci 2015; 22: E22-27
• 27 Patel R, Varadarajulu S, Wilcox CM. Endoscopic ampullectomy: techniques and outcomes. J Clin Gastroenterol 2012; 46: 8-15
• 28 Ben-Menachem T, Decker GA, Early DS. et al. Adverse events of upper GI endoscopy. Gastrointest Endosc 2012; 76: 707-718
• 29 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
• 30 Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009; 28: 3083-3107
• 31 Chung KH, Lee SH, Choi JH. et al. Effect of submucosal injection in endoscopic papillectomy of ampullary tumor: propensity-score matching analysis. United European Gastroenterol J 2018; 6: 576-585
• 32 Hyun JJ, Lee TH, Park JS. et al. A prospective multicenter study of submucosal injection to improve endoscopic snare papillectomy for ampullary adenoma. Gastrointest Endosc 2017; 85: 746-755
• 33 Okano N, Igarashi Y, Ito K. et al. Efficacy of hypertonic saline-epinephrine local injection around the anal side before endoscopic papillectomy for ampullary tumors. Clin Endosc 2021; 54: 706-712
• 34 van Wanrooij RLJ, van Hooft JE. Submucosal epinephrine injection before endoscopic papillectomy: less is more?. Clin Endosc 2021; 54: 627-628
• 35 Ramai D, Facciorusso A, Singh J. et al. Endoscopic management of ampullary adenomas in familial adenomatous polyposis syndrome: a systematic review with pooled analysis. Dig Dis Sci 2022; 67: 3220-3227
• 36 Li S, Wang Z, Cai F. et al. New experience of endoscopic papillectomy for ampullary neoplasms. Surg Endosc 2019; 33: 612-619
• 37 van Leerdam ME, Roos VH, van Hooft JE. et al. Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2019; 51: 877-895
• 38 Ridtitid W, Tan D, Schmidt SE. et al. Endoscopic papillectomy: risk factors for incomplete resection and recurrence during long-term follow-up. Gastrointest Endosc 2014; 79: 289-296
• 39 Yang J, Gurudu SR, Koptiuch C. et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest Endosc 2020; 91: 963-982
• 40 Moss A, Williams SJ, Hourigan LF. et al. Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut 2015; 64: 57-65